Pancreatic Cancer

A DCI team led by Peter Allen, MD, chief of Surgical Oncology, finds way to help determine likelihood of pancreas cysts becoming cancerous.

Daniel Nussbaum, MD, is one of 12 investigators to have been selected by National Cancer Institute for their Early-Stage Surgeon Scientist Program (ESSP).

In a global phase 1/2 clinical trial, sotorasib “demonstrated meaningful anticancer activity in patients with heavily pre-treated KRAS G12C–mutated advanced pancreatic cancer.”

Can a new test diagnose pancreatic cancer in the early stages?

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

Learn about some notable BRPC/DCI cancer research collaborations and why the partnership is core to winning big grants for cancer research.

A gift from the family of pancreatic cancer survivor Nancy Wright helps spread the sound of hope in the Duke cancer community. 

Clinical providers, researchers, staff & health leaders came together to celebrate the 50th anniversary of the Duke Comprehensive Cancer Center (now DCI).

"She is now five years out from completing her therapy for pancreatic cancer and is disease-free, and what we would consider cured.”

Long an advocate for others with cancer, Nancy Wright is in the midst of her second battle with the disease.

After a lengthy surgery failed to remove a cancerous mass from her pancreas, Sharlene Mitchell’s doctors told her nothing more could be done. Then she came to Duke.

The Donald Lab, led by Bruce Donald, PhD, is designing proteins for a historically undruggable protein that’s implicated in difficult-to-treat cancers like pancreatic cancer.

DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.

Updated genetic screening guidelines published by NCCN feature emerging evidence on personalized medicine.

ICYMI the AACI's Physician Clinical Leadership Initiative (PCLI) presented a two-part webinar series on hereditary cancer programs and cancer risk assessment.

Nancy Davenport-Ennis has survived cancer twice. One of her many strategies for thriving—look for ways to help others. Learn more about her patient advocacy.